JPWO2019203255A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019203255A5 JPWO2019203255A5 JP2020514407A JP2020514407A JPWO2019203255A5 JP WO2019203255 A5 JPWO2019203255 A5 JP WO2019203255A5 JP 2020514407 A JP2020514407 A JP 2020514407A JP 2020514407 A JP2020514407 A JP 2020514407A JP WO2019203255 A5 JPWO2019203255 A5 JP WO2019203255A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- cells
- administration
- emt
- anticancer drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 claims 19
- 201000011510 cancer Diseases 0.000 claims 19
- 239000002246 antineoplastic agent Substances 0.000 claims 6
- 229940041181 antineoplastic drug Drugs 0.000 claims 6
- 210000004027 cell Anatomy 0.000 claims 6
- 238000000034 method Methods 0.000 claims 5
- 210000002220 organoid Anatomy 0.000 claims 5
- 229940079593 drug Drugs 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 2
- 238000012216 screening Methods 0.000 claims 2
- 210000002536 stromal cell Anatomy 0.000 claims 2
- 210000003556 vascular endothelial cell Anatomy 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018080585 | 2018-04-19 | ||
| JP2018080585 | 2018-04-19 | ||
| PCT/JP2019/016421 WO2019203255A1 (ja) | 2018-04-19 | 2019-04-17 | 再構成癌組織を用いた薬剤評価方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2019203255A1 JPWO2019203255A1 (ja) | 2021-06-10 |
| JPWO2019203255A5 true JPWO2019203255A5 (cg-RX-API-DMAC7.html) | 2022-03-02 |
Family
ID=68238962
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020514407A Pending JPWO2019203255A1 (ja) | 2018-04-19 | 2019-04-17 | 再構成癌組織を用いた薬剤評価方法 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2019203255A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019203255A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021221179A1 (ja) * | 2020-04-28 | 2021-11-04 | 国立大学法人高知大学 | ヒト膵癌オルガノイドを用いたマウスモデルの樹立 |
| EP4174171A4 (en) | 2020-06-25 | 2024-03-27 | Next & Bio Inc. | Method for mass proliferation of stem cells without using hydrogel |
| US12606783B2 (en) | 2020-06-25 | 2026-04-21 | Next & Bio Inc. | Well plate and 3D culture plate comprising the same |
| WO2021261625A1 (ko) * | 2020-06-25 | 2021-12-30 | 주식회사 넥스트앤바이오 | 암을 가진 대상체의 항암제 및/또는 방사선 내성 진단에 필요한 정보를 제공하는 방법 |
| KR102746470B1 (ko) | 2021-07-09 | 2024-12-26 | 주식회사 넥스트앤바이오 | 가상 오가노이드 생성 방법 |
| KR102746473B1 (ko) | 2021-07-09 | 2024-12-26 | 주식회사 넥스트앤바이오 | 가상 오가노이드를 이용한 촬영 이미지 데이터 생성 방법 |
| WO2023238939A1 (ja) * | 2022-06-09 | 2023-12-14 | 慶應義塾 | 癌の再燃若しくは再発の予防剤又は治療剤及びそのスクリーニング方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2900969A1 (en) * | 2013-03-15 | 2014-09-25 | Oncomed Pharmaceuticals, Inc. | Methods of treating pancreatic cancer |
| WO2015153997A2 (en) * | 2014-04-04 | 2015-10-08 | Oncomed Pharmaceuticals, Inc. | Notch3 antibodies and uses thereof |
| WO2016089208A2 (en) * | 2014-12-04 | 2016-06-09 | Stichting Maastricht Radiation Oncology "Maastro-Clinic" | Sulfonamide, sulfamate and sulfamide derivatives of anti-cancer agents |
-
2019
- 2019-04-17 WO PCT/JP2019/016421 patent/WO2019203255A1/ja not_active Ceased
- 2019-04-17 JP JP2020514407A patent/JPWO2019203255A1/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Sun et al. | Therapeutic strategies targeting cancer stem cells and their microenvironment | |
| Shanmugam et al. | Thymoquinone inhibits bone metastasis of breast cancer cells through abrogation of the CXCR4 signaling axis | |
| Jiang et al. | Metformin and docosahexaenoic acid hybrid micelles for premetastatic niche modulation and tumor metastasis suppression | |
| Ribatti | The Chick Embryo Chorioallantoic Membrane in the Study of Angiogenesis and Metastasis: The CAM assay in the study of angiogenesis and metastasis | |
| Dang et al. | Local doxorubicin delivery via 3D‐printed porous scaffolds reduces systemic cytotoxicity and breast cancer recurrence in mice | |
| Cheikh et al. | Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention | |
| EP3750540A1 (en) | Choroidal neovascularization suppressor or drusen formation suppressor | |
| JP2008536487A5 (cg-RX-API-DMAC7.html) | ||
| Liu et al. | Sustained Release of Nitric Oxide‐Mediated Angiogenesis and Nerve Repair by Mussel‐Inspired Adaptable Microreservoirs for Brain Traumatic Injury Therapy | |
| Shin et al. | Immunomodulatory effects of perioperative dexmedetomidine in ovarian cancer: an in vitro and xenograft mouse model study | |
| Qian et al. | Ginsenosides: an immunomodulator for the treatment of colorectal cancer | |
| Zhao et al. | IKK inhibition prevents PM2. 5-exacerbated cardiac injury in mice with type 2 diabetes | |
| He et al. | Tumor-associated macrophages in colon cancer immunotherapy: mechanisms, natural product interventions, and microenvironment remodeling | |
| Naghinezhad | PI3K/AKT/mTOR pathway in ATLL: from basic biology to preclinical study | |
| Khanal et al. | Current insights of the potential plant bioactive compounds on modulating the mTOR signaling pathway in regulating oncological disorders | |
| Yin et al. | Nourishment of nerves and innervation: A novel approach for the treatment of myocardial infarction | |
| Cutter et al. | Advances in Naturally and Synthetically Derived Bioactive Sesquiterpenes and Their Derivatives: Applications in Targeting Cancer and Neurodegenerative Diseases | |
| DK2919791T3 (da) | Delphinidin-kompleks som antiflogistisk eller immunsuppressivt aktivt stof | |
| Ansari et al. | Targeting breast cancer signaling via phytomedicine and nanomedicine | |
| Xu et al. | Schisandrin C prevents regorafenib-induced cardiotoxicity by recovering EPHA2 expression in cardiomyocytes | |
| Ji et al. | Remodeling the tumor microenvironment: regulatory effects of β-sitosterol and luteolin on the immunosuppressive milieu in endometrial carcinoma and implications for combinatorial immunotherapy | |
| Yoon et al. | Effects of drying process for amorphous waxy maize starch on theophylline release from starch‐based tablets | |
| JP2014221752A (ja) | ガン幹細胞に対する分化促進薬及び脳腫瘍治療薬 | |
| Stephen et al. | A comparative study of once daily versus twice daily tacrolimus in liver transplantation | |
| Sailo et al. | Molecular alterations involved in pancreatic cancer chemoresistance and chemosensitization strategies |